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Abstract
The microcirculation is the site of oxygen exchange in the body, and little work has been done
to determine if different microvascular beds respond similarly to a simultaneous vascular
challenge. A hybrid microvascular monitoring device was developed that uses hyperspectral
near-infrared spectroscopy and diffuse correlation spectroscopy to simultaneously monitor the
brain and skeletal muscle. Experiments were conducted on Sprague Dawley rats (n=6,
156g6.4g) to discern the effect that phenylephrine (0.1 mL bolus, 10 mg/kg) has on the mean
arterial pressure (MAP), hemoglobin concentration, and blood flow in each microvasculature.
Hemoglobin concentration increased by 2.10.2 mmol in the brain, and decreased by 2.51.0
mmol in skeletal muscle. Cerebral blood flow increased by 20.87.2% while muscular blood
flow decreased by 7.51.5%. The response in the brain was dependent on the initial baseline
MAP. This non-invasive method can be used to aid in clinical translation of findings in animal
models.
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Summary for Lay Audience
The microcirculation is the distal functioning unit of the cardiovascular system, where small
blood vessels called capillaries are responsible for oxygen exchange. Red blood cells travel
through capillaries and transport the protein responsible for carrying oxygen in the body,
hemoglobin. The microcirculation regulates oxygen delivery, but the needs of the
microcirculation changes from organ to organ; muscular blood flow can change nearly 100fold, where cerebral blood flow must remain relatively constant.

Hemoglobin is a main light absorber in tissue, and we can take advantage of this light absorbing
property to monitor changes in its characteristics non-invasively using light-based methods.
This thesis accomplishes this by using two optical methods: hyperspectral near infrared
spectroscopy (h-NIRS) and diffuse correlation spectroscopy (DCS). The h-NIRS device uses
a white halogen lamp that was simultaneously directed at both the rat scalp to monitor the brain
and the rat left hind limb to monitor the skeletal muscle. The DCS device uses a laser, which
emits light at a single near-infrared wavelength, that was also simultaneously directed at both
the brain and the skeletal muscle. Multiple injections of a vasoconstrictor, which constricts
larger blood vessels like arteries and arterioles, were administered to increase blood pressure.

The purpose of this work was to develop a hybrid h-NIRS/DCS system that can simultaneously
monitor the microcirculation in the brain and in skeletal muscle, and to demonstrate that this
system can monitor changes in tissue dynamics. Comparing the results from the brain to those
from skeletal muscle, we found that the response of the brain depended highly on the baseline
blood pressure while the results for skeletal muscle do not. When blood pressure was low, there
was an increase of blood to the brain and vice versa. This difference in response between the
brain and skeletal muscle is likely due to strict regulation that occurs in the brain. This device
could be used in diseases like diabetes and sepsis that have been shown to have microvascular
deficits, as well as help bridge the gap between small animal disease models and what is seen
in patients.
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Chapter 1

1 Introduction
This introductory chapter will present the motivation for conducting the research presented
in this thesis. This section will focus on providing a background on skeletal muscle and
brain regulation mechanisms, the mechanism of action of phenylephrine, and an overview
of the theories and technologies of the light-based methods used herein. The aims and
objectives of the research are presented in the final subsection.

1.1 Microcirculation
Capillary networks are distal functioning units of the cardiovascular system, as oxygen
delivery and carbon dioxide removal occur at the capillary level (Fagrell, 1997), (Segal,
2005). Red blood cells (RBCs) are specialized to transport respiratory gases (Daly, 2013)
via the oxygen carrying protein, hemoglobin.
The microcirculation is often depicted as a tree-like structure of arteries, capillaries, and
veins, structurally arranged to optimize oxygen transport. Arteries and arterioles deliver
oxygenated blood to tissues, then venules and veins drain low oxygen blood from
capillaries and return it to the heart and lungs. The main determinant of geometric flow
resistance is the arteriolar tree and the available surface area for oxygen exchange is the
structure of capillary networks.
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Figure 1.1: Image derived from a video of the microcirculation illustrating the layout of
capillaries. The brighter and more yellow hued the pixel, the more red blood cells that
passed though the capillary during the collection time.

1.1.1 Blood Flow Regulation
A functional microcirculation must exert dynamic control over tissue oxygenation, despite
the short diffusion distance of oxygen from the blood into the surrounding tissue (Ellis,
2005), (Weibel, 1984). Capillary red blood cell hemodynamics determine convective
oxygen delivery of flowing blood (Lo, 2003), which can be denoted as capillary perfusion
within microvascular networks (Mendelson, 2021). The microvasculature must be
responsive to changes in metabolic demand and adjust flow accordingly.

The microvascular network, including arterioles, capillaries and venules, must act as a
coordinated vasomotor system that controls distribution of blood flow into tissues (Segal,
2005). Arteries and arterioles regulate the flow of oxygen-rich blood into capillaries.
Several control systems work in conjunction to accomplish this, including neural impulses,
circulating hormone factors, local myogenic responses, and retrograde conducted vascular
signaling (Segal, 2005), (Clifford, 2011). When it comes to supporting metabolic demand,
the oxygen requirements of tissue must have a close relationship to oxygen supply.
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Skeletal muscle is the largest organ by mass, and the largest capillary bed in the body
(Poole, 2013). It also has the widest range in metabolic requirements, as muscular blood
flow can change nearly 100-fold and therefore it needs robust regulation methods for
dealing with the large swings in oxygen demand (Thomas, 2004), (Murrant, 2015), (Poole,
2013). Regulation in skeletal muscle is a complex system, as even microvascular
architecture is not static (Ellsworth, 2016). Regulatory control is based on pressure
(myogenic control) and flow rate (shear stress) that control arteriolar vessel diameter, while
neural, humoral, and metabolic regulatory systems adjust systemic and local microvascular
pressure and flow. In capillaries, where the diameter often mirrors the diameter of RBCs,
the assumption that blood acts as a uniform liquid no longer holds true. As seen in (Ellis,
1992) RBCs travel single file though capillaries, interspersed with plasma gaps. Many
theories have been suggested that would explain the mechanisms of increased blood flow
to skeletal muscle, including oxygen sensitivity in arterioles (Pittman, 1973), the release of
nitrite from arterioles (Gladwin, 2004), and two RBC-dependent mechanisms. RBCs are
the “best” choice of oxygen sensor since they carry oxygen, which has led to a few
proposed methods of RBC-based regulation. The first concerns the release of S-nitrothiol
- the deoxygenation of hemoglobin has been shown to release S- nitrothiol (Stamler, 1997).
It is thought to cause vasodilation in arterioles, however this method of oxygen regulation
has been rebutted (Patel, 1999), (Gladwin, 2003). The more likely theory concerns the
release of ATP from RBCs (Ellsworth, 1995), (Ellsworth, 2016). The RBC releases ATP
to induce an increase in oxygen supply to specific regions of tissue. The amount of ATP
released from RBCs directly relates to the oxygen needs of the tissue bed (Jagger, 2001).
This model has been supported by various theoretical papers and models (Ellis, 2010),
(Ellsworth, 2009), (Goldman, 2012) as well as in vivo evidence (Ghonaim, 2021), (Sové,
2021).

Comparatively, the brain does not have such dramatic swings in oxygen requirements.
Cerebral blood flow (CBF) is an important biomarker of brain health and function and CBF
impairment is a direct cause of clinical conditions such as ischemic stroke (Durduran,
2014). Much like any other tissue bed, the cerebral vasculature is a highly complex,
interconnected network of vessels. Blood is supplied to the brain though 4 main vessels,
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but after this stage the vasculature mimics the skeletal muscle structure described above:
blood passes into arterioles, then capillaries, and drains through venules into veins. Due to
the high metabolic demand in the brain, it requires continuous CBF. CBF is controlled by
a process called cerebral auto regulation (CAR). CAR is the intrinsic ability of the cerebral
vasculature to maintain consistent blood flow despite changes or fluctuations in cerebral
perfusion pressure (Lassen, 1959) and it typically works when the mean arterial pressure
is between 60 and 150 mmHg (Paulson, 1990). CAR is especially important as the brain
has no way to store oxygen within the organ, therefore any disruption in supply would
quickly result in tissue oxygenation depletion and metabolic stress (Boas, 2011). CAR
closely controls CBF by modulating vascular resistance (Paulson, 1990), as autoregulation
is achieved almost entirely through the control of vessel radius (Payne, 2016). Nearly all
accepted models of autoregulation revolve around feedback via arterial compliance. Four
mechanisms are proposed for autoregulation: myogenic, neurogenic, metabolic, and
endothelial (Armstead, 2016). In severely challenging circumstances, normal regulation
methods may be overwhelmed. Instead, neurogenic and sympathetic control may take over
(ter Laan, 2013). Much like skeletal muscle regulation, CAR is not completely understood
as there is no consensus on which CAR assessment or monitoring approach should be
considered the gold standard (Liu, 2020). However, it is generally regulated through
changes in arteriolar diameter which drive changes in vascular resistance (Budohoski,
2013), (Fog, 1938), (Kontos, 1978), (Symon, 1973). In response to variation in arterial
blood pressure, and therefore cerebral perfusion pressure, cerebral vascular resistance will
adapt to return CBF to acceptable levels. Cerebral perfusion pressure is not the only
variable, as vascular smooth muscle cells can also modify cerebral vascular resistance in
response to a carbon dioxide stimulus (Hoiland, 2019). In addition, recent work looking at
regional differences in cerebral vascular resistance concluded that assuming the effect on
the middle cerebral artery could be applied across the brain is likely incorrect (Ainslie,
2009), (Skow, 2013). Therefore, the gold standard for measurement needs to have an
approach that improves on the regional accuracy.
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1.1.2 Phenylephrine
The microvasculature responds to changes in metabolic demand caused by a variety of
endogenous and exogenous compounds. Phenylephrine is a commonly used drug that,
when given intravenously, is an effective vasopressor in a variety of clinical settings
(Ertmer, 2009). It binds to adrenergic receptors and induces contraction of vascular smooth
muscle cells. This vasoconstriction can last up to twenty minutes in humans, with the
maximum blood pressure occurring one-minute post injection (Ertmer, 2009), (Dancker,
2018). Phenylephrine is routinely used in cardiac surgery, to increase mean arterial
pressure and systemic vascular resistance without affecting cardiac output.

Despite the well-known effects of phenylephrine on mean arterial pressure, its effects on
the microcirculation are unclear; phenylephrine has been shown to either significantly
decrease microvascular oxygen saturation and blood flow (Maier, 2009), (Poterman, 2015),
(Van Leishout, 2008), (Meng, 2011) or cause no change (Strandgaard, 2008),
(Hengstmann, 1982), (Faraci, 1990) in various microvascular beds and patient populations.
One location of interest is skeletal muscle; as mentioned previously microvascular blood
flow in skeletal muscle is controlled by a variety of regulating sympathetic mechanisms
(Ogoh, 2011). Phenylephrine disrupts the sympathetic nervous control of skeletal muscle
by binding to -adrenergic receptors causing vasoconstriction (Christensen, 2017). This
vasoconstriction in skeletal muscle is responsible for the increase in blood pressure seen
with phenylephrine administration. This causes an increase in flow in most organs. An
exception to this may be the brain, which is what makes the brain an additional region of
interest. Cerebral autoregulation plays a central role in regulating the cerebral
microcirculation, which is done by tightly regulating cerebral blood flow by modulating
processes such as vascular resistance (Paulson, 1990). Studies have shown that resistance
in large arteries and microvascular vessels are both affected by circulating vasoconstrictors
(Faraci, 1990), and it has been further shown that cerebral autoregulation can be impaired
by phenylephrine (Meng, 2011), (Hudlicka, 2011). Thus, there is a need to determine the
effects of this commonly used drug on cerebral and skeletal muscle microcirculation.
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1.2 Measuring Blood Flow
Non-invasive methods for measuring microvascular blood flow include single-photon
emission computed tomography (SPECT), positron emission tomography (PET), MRI
with contrast agents, Doppler ultrasound, and arterial spin labeling (ASL) MRI.
However, standard radiological methodologies (MRI, PET, CT) are obviously not
practical for continuous monitoring and often require a tracer or a contrast agent.
Transcranial Doppler is limited to observations of larger blood vessels and not the
arterioles and capillaries (Li, 2021).
Two alternative options for non-invasive microvascular monitoring are Near Infrared
Spectroscopy and Diffuse Correlation Spectroscopy. A more detailed description of each
modality is provided in sections 1.3 and 1.4, respectively.

1.3 Near-Infrared Spectroscopy
Near Infrared Spectroscopy (NIRS) is a non-invasive, light-based method that illuminates
tissue with near infrared light to measure the concentration of chromophores. NIRS
typically uses light in the 650-1000nm range to penetrate more deeply into tissue than
visible light (Jobsis, 1997), (Fantini, 2018). NIRS measurements of hemoglobin
concentration changes in the brain through the intact skull are feasible because of weak
absorption of NIR light by hemoglobin and the other tissue chromophores, and relatively
small tissue scattering as first demonstrated by (Jobsis, 1977). In the NIR window, there
are only a few endogenous chromophores that have distinct absorption features and a large
enough concentration to be easily measured with NIRS. The most physiologically
significant of these is hemoglobin, whose molar extinction coefficient depends on oxygen
saturation (SO2) of the hemoglobin molecule, and is wavelength dependent (Kewin, 2018).
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Figure 1.2: Absorption spectra of both oxygenated hemoglobin (blue) and deoxygenated
hemoglobin (red) in the near infrared (NIR) range (650-1000nm).
As mentioned previously, hemoglobin is the oxygen carrying protein in blood and is
therefore an ideal candidate for monitoring tissue oxygen saturation. The spectral features
of hemoglobin allow for the concentration of each of its states (oxygenated and
deoxygenated) to be continuously monitored by quantifying the amount of NIR light
absorption at several wavelengths within the spectral range.

1.3.1 Principles of NIRS
Modelling of light propagation through tissue has led to the ability to estimate
physiological parameters such as blood flow and tissue oxygenation, due in large part to
the quantification of the absorption and scattering coefficients using analytical models such
as the diffusion approximation to the radiative transfer equation (Boas, 1997), (Yodh,
1995), (Delpy, 1997).
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The device used in this thesis is based on continuous-wave, hyperspectral NIRS (h-NIRS)
technology. There are two other NIRS technologies, namely frequency-domain and timeresolved but their discussion is outside the scope of this thesis. Continuous-wave is the
simplest and most widely used type of NIRS, where light of constant intensity is used to
probe the tissue of interest. Most commercial NIRS devices use just a few (2-3); Hb and
HbO are quantified by measuring light attenuation at these wavelengths, then a model is
applied to convert the measurements into hemoglobin concentrations (Strangman, 2003).
In contrast, hyperspectral NIRS measures light absorption at dozens of wavelengths to
allow for more accurate estimation of the concentration of Hb and HbO (Kewin, 2019);
the hyperspectral NIRS device used in this thesis cover the wavelengths of 650-1000nm.
The approach used in this thesis was adopted from (Diop, 2015). Light propagation in the
probed tissue was modeled using a solution to the diffusion approximation for a semiinfinite homogenous medium, which characterizes the light in terms of the absorption
coefficient (μa) and the reduced scattering coefficient (μs´) (Fantini, 1994). The
wavelength-dependent reduced scattering coefficient can be expressed as (Jacques,
2013):

𝜆

−𝑎

𝜇𝑠′ = 𝐴 (800)

(1.1)

where A is the μs´ value at 800nm, and 𝑎 is the scattering power. The absorption coefficient
is given by its relationship with the concentration of oxygenated hemoglobin (HbO),
deoxygenated hemoglobin (Hb), and water:
𝜇𝑎 (𝜆) = [𝐻𝑏𝑂] ∙ 𝜀𝐻𝑏𝑂 (𝜆) + [𝐻𝑏] ∙ 𝜀𝐻𝑏 (𝜆) + 𝑊𝐹 ∙ 𝜀𝐻2 𝑂 (𝜆)

(1.2)

where () represents the extinction coefficient of Hb and HbO, and WF is the tissue water
fraction. While not explicitly provided in this work, the estimated concentrations of
deoxygenated and oxygenated hemoglobin can be used to compute tissue oxygenation
(Diop, 2014).
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Total hemoglobin (HbT) is the sum of Hb and HbO, and is a clinically relevant measure of
blood oxygen transport capacity (Hayashi, 2020). It is determined by:
𝐻𝑏𝑇 = 𝐻𝑏 + 𝐻𝑏𝑂

(1.3)

1.3.2 NIRS in Tissue
The light that reaches larger vessels such as arteries and veins is almost completely
absorbed due to the higher amount of hemoglobin that travels through these vessels; as
such, NIRS light effectively interrogates the microcirculation (De Backer, 2012), (Taylor,
1996), (Boushel, 2000). A non-invasive oxygen sensor would have significant clinical
utility for assessing tissue injury and disease that give rise to impaired oxygen delivery
and/or utilization, and would be important for following tissue response to therapy (Boas,
2011). Other advantages of NIRS include its portability, ability to accomplish noninvasive monitoring, and its relative low cost. The main organs that are interrogated with
NIRS are skeletal muscle and the brain (Barstow, 2019), (Ferrari, 2012), (Hilty, 2019) but
monitoring of other organs have also been investigated. Notably, NIRS has been used to
study a variety of muscle groups in humans as outlined nicely in various review articles
(Hamaoka, 2007), (Ferrari, 2011), (Jones, 2017), (Barstow, 2019). Further, since the brain
exhibits a high rate of oxygen metabolism (Edvinsson, 1993), it is not surprising that
majority of NIRS studies have been focused on the brain (Durduran, 2014). NIRS was first
used in the human brain by (Brazy, 1985) and has been used successfully applied many
times since (Arora, 2013), (Milej, 2020), (Abdalmalak, 2020), (Kewin, 2019), (Lange,
2019), (Diop, 2012), (Diop, 2010), (Elliot, 2010). Limitations of NIRS include signal
contamination by skull and/or adipose tissue, the unknown effect of myoglobin on the
signal, and the effect of blood volume changes on optical pathlength (Ferrari, 2004).
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1.4 Diffuse Correlation Spectroscopy
Diffuse correlation spectroscopy (DCS) is an optical technique that utilizes NIR light to
directly and non-invasively measure local microvascular blood flow (Durduran, 2010).
DCS has a lot of the same advantages as NIRS (i.e., non-invasive, cost effective) but with
the added benefit of measuring blood flow without the need for a tracer or contrast agent
(Busch, 2018), (Boas, 1995), (Buckley, 2014). DCS can monitor blood flow with high
temporal resolution by measuring temporal intensity fluctuations in coherent light, which
are characterized by generating an autocorrelation function (Guoqiang, 2005), (Boas,
1995). Higher flow rates lead to a loss of coherence which translates into a decrease in
autocorrelation. This relationship allows for the measurement of blood flow via a blood
flow index (BFI) (Diop, 2011), (Selb, 2014), (Boas, 2016), (Boas, 1995). DCS
measurements are often converted into blood flow index (BFI), which is a relative blood
flow measurement obtained by computing the changes in the diffusion coefficient relative
to a baseline period (Li, 2021). Although BFI doesn’t have traditional or absolute blood
flow units, it is directly proportional to tissue blood flow (Diop, 2011), (Li, 2015), (He,
2018).

Summarized from (Verdecchia, 2016), the theory behind DCS is outlined below. NIR
photons undergo multiple scattering interactions with RBCs in tissue. The electric fields of
the photons that emerge from the tissue interfere at the surface of the skin either
constructively or destructively to produce bright and dark spots (speckle pattern). Moving
RBCs cause fluctuations in the speckle pattern; when the RBCs move faster (slower), these
fluctuations change quicker (slower), causing a decrease (increase) in temporal coherence.
This measure of the degree of phase correlation can be used to assess changes in tissue
perfusion by computing an autocorrelation function from the measured intensity
fluctuations.
Furthermore, in the 1990’s, there was a discrepancy between two well-known theories that
describe energy transfer: radiative transport and correlation transport (Ackerson, 1992).
Radiative transport assumes that energy is conserved, while correlative transport does not;
however, this difference can be explained by scattering. Applying this difference to a
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highly scattering, low absorbing media lead to the correlation diffusion equation (Boas,
1995). This equation can be solved to generate a model that characterizes RBC motion in
the microcirculation, as RBC motion is the predominant cause of the loss of coherence
(Ninck, 2010). In this thesis, since the thickness of the rat skin and skull (when relevant) is
relatively thin, we assumed that the tissue under investigation was a semi-infinite
homogenous medium.

Due to the reliance of DCS analysis on coherence, the quality of the light source is crucial;
a single wavelength, long-coherence laser is needed. The long coherence length is
important to ensure the light is in phase after traveling a relatively large distance through
the tissue. This ensures any decorrelation is due to interactions with scatterers, and not from
the source itself. Further, a single mode or a few mode detection fibre and a NIR lightsensitive single photon counting module are required. A single mode detection fibre has a
small diameter to ensure that only one or a few speckles are sampled, and the single photon
counting module allows for high signal to noise ratio.

1.4.1 DCS in Tissue
DCS was first used in tissue in the early 2000s and has been growing in popularity ever
since (Buckley, 2014), (Mazumder, 2021). DCS has been extensively validated through
comparisons with various techniques, including Doppler ultrasound (Buckley, 2009),
(Roche-Labarbe, 2010), Xenon CT (Kim, 2010), MRI (Milej, 2019) and others (Zhou,
2009), (Durduran, 2004), (Yu, 2007), (Diop, 2011). DCS has significant advantages in
measuring BFI: the relatively large interrogation depth (Ubbink, 1993), (Chen, 1997)
sensitivity to the microcirculation, and lack of radiation exposure. The main limitation of
DCS is the possibility for signal contamination from extracerebral tissues, causing an
underestimation of CBF (Verdecchia, 2016).
The application of DCS to neuromonitoring is gaining traction, with many studies done in
piglets (Zhou, 2009), (Verdecchia, 2013) and neonates (Rajaram, 2020), (Roche-Labarbe,
2010) thanks to their thin skull thickness. The use of DCS in muscle focuses heavily on
exercise induced effects, such as handgrip exercises (Rosenberry, 2019), cycling
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(Quaresima, 2019), and flexion (Shang, 2010), (Yu, 2005). An understudied field of
research is using DCS to quantify the outcomes of drugs with vasoconstricting/dilating
effects on the heterogeneity of skeletal muscle.

1.5 NIRS and DCS Used Together
Individually, NIRS and DCS have demonstrated their ability to accurately detect diseaseor bolus-induced physiological changes in tissues. However, using NIRS and DCS together
has the potential to provide more robust measures. For example, HbT and blood flow are
proving to be better indicators of tissue status compared to SO2 alone (Meek, 1999), (Grant,
2009), and even better when combined with CBF to estimate oxygen consumption (Yoxall,
1998), (Roche-Labarbe, 2010), (Durduran, 2010). It has been shown that SO2 alone is not
robust enough (Weiss, 2005), and NIRS can only be used to directly measure CBF if a
tracer is used (Durduran, 2014), (Diop, 2010). However, combining hemoglobin
concentration, oxygen saturation, and blood flow has been shown to be a robust indicator
of tissue viability (Christensen, 2017).

The largest roadblock in combining these two systems is ensuring that no cross-talk occurs
between the two systems, as they both operate in the same wavelength range. A popular
solution is using a multiplexing approach based on mechanical shutters to ensure only one
system is transmitting and receiving light at a time (Rajaram, 2018), (Mawdsley, 2021).
While this solution does not allow for a true simultaneous collection, shutter cycles can be
relatively short (~3 seconds) to ensure adequate temporal resolution.

First introduced in rats to collect blood flow and oxygen saturation data (Cheung, 2001),
hybrid h-NIRS/DCS systems have proven beneficial for continuous in vivo monitoring in
piglets (Verdecchia, 2013), humans (Rajaram, 2020), (Rajaram, 2018), and in multiple
microvascular beds in rats (Mawdsley, 2021). Incorporation of h-NIRS/DCS into the
same instrumentation creates a new opportunity to make comprehensive, all-optical
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measurements of cerebral hemodynamics and cerebral oxygen metabolism (Durduran,
2014).

1.6 Research Objectives
The increasing wide-spread use of hybrid NIRS/DCS systems opens doors for a variety of
important insights into normal physiology and pathological conditions. An overlooked
advantage of these systems is the possibility to not only simultaneously monitor the
vasculature using two techniques, but also the monitoring multiple microvascular beds
simultaneously. Determining the effect of an intervention in one organ (i.e., the brain) is
important, but determining the effect on two+ organs simultaneously can provide
additional insight into how the body works as a whole, and how the responses of the
different microvascular beds may differ.

This work focused on developing a hybrid h-NIRS/DCS system that can achieve nearsimultaneous monitoring of two microvascular beds in live animals: the brain and skeletal
muscle. This is the first report of simultaneous monitoring of the cerebral and muscular
microcirculation, and the first to concurrently monitor the effects of phenylephrine on
blood pressure, the brain, and skeletal muscle. This work lays the ground for future studies,
such as monitoring the time course of microvascular response in diseases like sepsis and
diabetes, and the effects of commonly used drugs on multiple organs.

The specific objectives of this work were as follows:
1. Develop a hybrid h-NIRS/DCS system for use in small animals (rats specifically) that
can simultaneously monitor the microcirculation in the brain and in skeletal muscle.
2. Demonstrate that the system can monitor changes in tissue hemodynamics by inducing
a vascular challenge. This was provided by injection of a vasoconstrictor –
phenylephrine – and subsequent monitoring.
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Chapter 2

2 In vivo monitoring of the effects of phenylephrine on the
cerebral and musculoskeletal microvasculature with
hyperspectral near-infrared spectroscopy and diffuse correlation
spectroscopy
2.1

Introduction

The microcirculation is the distal functioning unit of the cardiovascular system, where
blood moves through the vasculature via arterioles, capillaries and venules. A productive
microcirculation must exert dynamic control over tissue oxygenation (Ellis, 2005), and for
this to occur, the microvasculature must be responsive to changes in metabolic demand or
challenges to oxygen supply and adjust blood flow accordingly (Segal, 2005).

The microvasculature responds to a variety of endogenous and exogenous compounds,
such as hormones and medications. Phenylephrine is a commonly used drug that, when
given intravenously, is an effective vasopressor in a variety of clinical settings (Ertmer,
2009). It binds to adrenergic receptors and induces contraction of vascular smooth muscle
cells resulting in increased peripheral vascular resistance and blood pressure. This
vasoconstriction can last up to twenty minutes in humans, with the maximum blood
pressure occurring one-minute post injection (Ertmer, 2009), (Dancker, 2018).
Phenylephrine is routinely used in cardiac surgery, to increase mean arterial pressure and
systemic vascular resistance without affecting cardiac output, and often in sepsis-related
arterial hypotension (Ertmer, 2009).

Despite the well-known effects of phenylephrine on mean arterial pressure, its effects on
the microcirculation are inconsistent in organs such as the brain and peripheral tissue (Van
Leishout, 2008), (Meng, 2011), (Strandgaard, 2008). Phenylephrine has been shown to
either significantly decrease microvascular oxygen saturation and blood flow (Maier,
2009), (Poterman, 2015), (Van Leishout, 2008), (Meng, 2011) or cause no change
(Strandgaard, 2008), (Hengstmann, 1982), (Faraci, 1990) in various microvascular beds
and patient populations.
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One location of interest is skeletal muscle; microvascular blood flow in skeletal muscle is
controlled by a variety of regulating mechanisms, including nervous, hormonal, myogenic,
and endothelial (Hudlicka, 2011). Phenylephrine affects the sympathetic nervous control
of skeletal muscle by binding to -adrenergic receptors causing vasoconstriction (Ogoh,
2011). An additional region of interest is the brain, as cerebral autoregulation plays a key
role in regulating the cerebral microcirculation. This is done by tightly regulating cerebral
blood flow in response to changes in arterial blood pressure by modulating processes such
as vascular resistance (Paulson, 1990). Studies have shown that resistance in large arteries
and the microvasculature are both affected by circulating vasoconstrictors (Faraci, 1990),
and it has been further shown that cerebral autoregulation can be impaired by
phenylephrine (Meng, 2011), (Christensen, 2017). However, there is a lack of data on the
effect of phenylephrine on the cerebral microcirculation. Current literature implements a
variety of monitoring methods with different temporal resolutions, preventing direct
comparison of results between studies (Van Leishout, 2008), (Meng, 2011), (Strandgaard,
2008), (Strandgaard, 2008), (Hengstmann, 1982). Thus, there is a need to determine the
effects of this commonly used drug on cerebral and skeletal muscle microcirculation.

Non-invasive monitoring of the microcirculation has become viable due to recent
developments in optical technologies. One cost-effective method is hyperspectral near
infrared spectroscopy (h-NIRS), which uses a broadband light source and a spectrometer
to quantify changes in hemoglobin concentration and tissue oxygen saturation (Boas,
2011). Similarly, diffuse correlation spectroscopy (DCS) uses near infrared light to monitor
changes in blood flow by analyzing temporal fluctuations of light scatter from red blood
cells in the microvasculature. Combining these technologies to monitor hemoglobin
concentration, oxygen saturation, and blood flow has been shown to be a robust indicator
of tissue viability (Durduran, 2014). Hybrid h-NIRS/DCS systems have proven beneficial
for continuous in vivo monitoring (Rajaram, 2020a), (Rajaram, 2020b), and provide a
unique methodology for concurrent monitoring of hemodynamic parameters.

Using h-NIRS and DCS simultaneously to directly and continuously monitor
hemodynamics in the brain and skeletal muscle microcirculation during a phenylephrine
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injection will provide insight into the timing and impact of vasoconstriction on major
microvasculature beds. The objective of the current study is to compare the effects of a
timed phenylephrine bolus on the brain and skeletal muscle microvasculature.

2.2 Methods
2.2.1 Instrumentation
The monitoring device (Fig. 2.1A) was a hybrid h-NIRS/DCS system similar to the system
reported by Rajaram (2018). The h-NIRS subsystem used a 20 W halogen light source
(Ocean Insight HL-2000, FL, USA) whose output was simultaneously directed to the scalp
and skeletal muscle via a bifurcated optical fibre bundle. Reflected light was collected with
two fibre bundles (one on the scalp and one on the skeletal muscle, core = 400 m,
numerical aperture = 0.22, Thorlabs, NJ, USA) and guided back to two solenoid shutters
(Digi-Key Electronics, MN, USA). A second set of identical fibre bundles guided light
from the shutters’ output to the two Ocean Insight spectrometers (MayaPro and QE65000,
FL, USA); the MayaPro spectrometer monitored the brain and the QE65000 spectrometer
collected measurements from the hind limb. The DCS subsystem used a 785 nm long
coherence diode laser (CrystaLaser) with the output passing through a variable neutral
density filter (NDC-100C-4M, Thorlabs, NJ, USA) into a bifurcated fibre bundle
(core = 400 m, numerical aperture = 0.22, Thorlabs, NJ, USA). Light then passed through
a shutter into a second fibre bundle (core = 400 m, numerical aperture = 0.22, Thorlabs,
NJ, USA) that directed light into the target tissue (brain or skeletal muscle). A single mode
fibre (core = 4.4 m, numerical aperture = 0.13, Thorlabs, NJ, USA) collected the reflected
light and brought it to a single photon counting module (SPCM, Laser Components,
Germany). Fibre ends that collected light from tissue were fitted into a custom 3D printed
probe holder (Fig. 1B) designed to be positioned on the left hind limb and the scalp. The
source-detector distance was 10 mm for both the h-NIRS and DCS subsystems. Operation
of both systems at the same time would result in cross-talk and compromised data, so
shutters were used to ensure both light sources were not simultaneously illuminating the
tissue. The control and timing of both subsystems originated from a TTL signal received
from an in-house software built in LabView, which also controlled the 20 W light source
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and four solenoid shutters − two between the DCS light source and the animal and two
between the animal and the spectrometers (Fig. 2.1).

Figure 2.1: Schematic of the hybrid h-NIRS/DCS system (A) and probe holder (B). In
(A), the red lines represent the h-NIRS signal path, and the black dashed lines represent
the path of the DCS signal. In (B), the “E” represents the emission probes and the “D”
represents the detection probes. Note that figures are not to scale.

2.2.2 Animal Protocol
2.2.2.1 Animal Model
This study was approved by Western University’s Animal Care and Use Committee. Data
were collected from male Sprague Dawley rats (n=6, 1566.4g). Rats were anesthetized
(pentobarbital, 65 mg/kg), then the carotid artery was cannulated to monitor blood pressure
and the jugular vein was cannulated for the purpose of administering anesthetic and
phenylephrine. A tracheotomy was performed to connect the rat to a ventilator to control
breathing rate and ensure proper oxygen concentration in the administered gas mixture.
0.9% heparinized saline was used in the arterial flush line to prevent clotting and 0.9%
saline was continuously infused through the venous line at a rate of 0.5 mL/hr. The core
temperature of the animal was maintained at 370.5 C using a rectal temperature probe
and a heat mat. At this point, approximately 100 L of arterial blood was collected and
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analyzed using a portable point-of-care device (Vetscan iStat 1) to confirm healthy levels
of blood gases (i.e., PO2, PCO2, pH) and lactate levels. Heart rate, temperature, and mean
arterial pressure were monitored continuously throughout the experiment. An additional
100 L of arterial blood was collected at the end of the experiment and analyzed with the
same blood testing device.

2.2.2.2 Experimental Protocol
Once the surgery was completed, the fur on the top of the cranium and the left hind limb
was removed with depilatory cream, and the background and reference spectra of the hNIRS sub-system were acquired. One at a time, 6-8 injections were performed at 12-minute
intervals: four to six boluses of a microvascular challenge, and 1-2 injections of a control
(0.9% NaCl) solution. Measurements were obtained by recording baseline data for two
minutes followed by a two-second injection of 0.1 mL of a phenylephrine-saline solution
(10mg/kg of phenylephrine mixed with 0.9%NaCl solution (Yeh, 1999)) through the
intravenous line. The line was then hand-flushed with 0.1mL of saline to ensure full and
consistent dosing. DCS and h-NIRS measurements were acquired for 8 further minutes.
Data were collected near-simultaneously thanks to the shutter multiplexing system. As
shown in Figure 2.2, each modality collected data for 1 second, then all shutters were closed
for 0.1 second, to account for any potential jitter, then the shutter for the next modality
opened to collect data. The light source for the subsystem not in use was blocked by a
shutter during the recording. The total length of a cycle was 3.3 seconds.
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Figure 2.2: Schematic of the timing for the h-NIRS/DCS system. The system starts with
0.1sec of dark time, then opens the shutters for the h-NIRS halogen lamp and both
spectrometers. After 1sec, the shutters for the halogen lamp and the spectrometers close
and 0.1sec of dark time occurs. Next, the shutter for the brain DCS light source opens for
1 second, closes again for 0.1 second, and finally the shutter for the muscle DCS light
source. The cycle repeats until the 10-minute of acquisition time is complete.

2.2.3 Data Processing
2.2.3.1 h-NIRS Data
For each challenge, the reflectance was calculated using the spectrum collected from the
Maya and QE spectrometers using equation 1 (Diop, 2014):
𝑅(𝜆) =

𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚𝜆 − 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑𝜆
𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝜆 − 𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑𝜆

(2.1)

where R() is the reflectance, spectrum is the spectrum measured from the animal,
background is the background noise in spectrum from the spectrometer, and reference is
the reference spectrum obtained from the light source.
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Concentrations of chromophores (i.e., water, deoxygenated hemoglobin (Hb), and
oxygenated hemoglobin (HbO)) were computed using the methods described by Diop
(2015). Briefly, the first and second derivatives of R() were fitted to the first and second
derivatives of a solution to the diffusion approximation for a semi-homogenous medium
(Fantini, 1994). The wavelength-dependent reduced scattering coefficient (s) was
modelled as:
𝜇𝑠 = 𝐵(

𝜆 −𝑎
)
800

(2.2)

where B represents the s value at  = 800 nm, and a is the scattering power. The
absorption coefficient (a) was defined as:
𝜇𝑎 (𝜆) = [𝐻𝑏𝑂] ∗ 𝜀𝐻𝑏𝑂 (𝜆) + [𝐻𝑏] ∗ 𝜀𝐻𝑏 (𝜆) + [𝑊𝐹] ∗ 𝜀𝐻2 𝑂 (𝜆)

(2.3)

where () represents the extinction coefficient of Hb and HbO, and WF is the tissue water
fraction.
Concentrations of each chromophore were determined by using a two-step, multiparameter fit for the first and second derivatives of the measured reflectance (Diop, 2015).

2.2.3.2 DCS Data
The blood flow index (BFI) was estimated using the methods described by Diop (2011).
The dynamics of the moving light scatterers in the brain and skeletal muscle can be
assessed by measuring the temporal dependence of the normalized intensity autocorrelation
function which is related to the electric field autocorrelation function G1(,) by the Seigert
relation (Cheung, 2001):

𝑔2 (, ) = 1 + 𝛽

|𝐺1 (,)|2
{I(,)}

(2.4)
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where  is the coherence factor, G1(,) is the solution to the diffusion equation and
{I(,)} represents the average detected intensity.

In highly scattering, low absorbing media the solution to the diffusion equation for large
distances is G1(,). In this work, the data were analyzed using the solution to the diffusion
equation for a semi-infinite homogenous medium (Diop, 2011):

𝐺1 (, ) =

3s exp(−𝑘𝐷 𝑟1 )
4𝜋

(

𝑟1

−

exp(−𝑘𝐷 𝑟2 )
𝑟2

)

(2.5)

The BFI was estimated by fitting the electric field autocorrelation curves obtained from the
DCS measurements with a solution to the diffusion approximation for a semi-infinite
homogenous medium (Fantini, 1994). The solution depends on the known source detector
distance (10 mm), the tissue optical properties (a, s), and the coherence factor. Each
autocorrelation curve was fit over a range of correlation times (1-10s) with blood flow
index and the coherence factor as the fitting parameters, and a and s set to their values
for 785 nm, obtained from the h-NIRS analysis.

For both h-NIRS and DCS, data for all runs were averaged, and the standard error was
calculated. Data are presented as a mean with standard error when appropriate. Analysis
and statistical analysis were done with MATLAB_R2016b, using the Statistics tool box.

2.3 Results
Figure 2.3 shows data collected from all 3 data acquisition methods (blood pressure
monitor, h-NIRS, and DCS) for a representative bolus. Figure 2.3A is illustrative of the
systemic response to the bolus, as it is the rolling average of the mean arterial blood
pressure (MAP) throughout the ten-minute capture. MAP increases by 38 mmHg
immediately following the bolus, and slowly returns to baseline levels over the
measurement period. Figures 2.3B and C show the percent change in cerebral (B) and
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muscular (C) blood flow. Figures 2.3D and E show the absolute change in total hemoglobin
in the brain and skeletal muscle, respectively.

As shown in Table 1, the cerebral blood flow increased post-bolus in some cases but
decreased in others. However, by splitting the data based on the baseline MAP (using a 95
mmHg threshold), we realized that all CBFs measured at a baseline MAP lower than 95
mmHg increased post-bolus while all the CBFs acquired at a baseline MAP higher than 95
mmHg decreased. The mean arterial pressure across all boluses that increased, increased
by 315.4 mmHg (Fig. 2.4A). The MAP across all boluses where CBF decreased,
increased by 294.3 mmHg (Fig. 2.4B). The average baseline MAP for the increased CBF
was 20 mmHg higher than the cases when CBF decreased (Fig. 2.4A). For the CBF increase
dataset, total hemoglobin and cerebral blood flow also increased by 2.10.2 mmol, and
20.87.2%, respectively (Fig. 2.4C, 2.4E). Both total hemoglobin and CBF returned to a
value slightly above baseline by the end of the 10-minute acquisition period. For the CBF
decrease dataset, total hemoglobin decreased by 1.21.6 mmol immediately following the
bolus and returned to baseline levels the end of the collection period (Fig. 2.4D); CBF
decreased by 4.41.4% immediately following the bolus, then returned to baseline levels
(Fig. 2.4F).

In contrast to the brain, the muscular blood flow response was consistent. Figure 2.5
displays the same data (mean arterial pressure, change in total hemoglobin, blood flow) for
all boluses. MAP increased by 3014.9 mmHg (Fig. 2.5A) in this dataset, with pressure
returning to a value slightly above baseline by the end of the measurement period. Total
hemoglobin and blood flow both initially decreased by 2.50.9 mmol and 7.61.4%,
respectively (Fig. 2.5B, 2.5C) before returning to baseline levels. Figure 2.6 shows the
relationship between the average baseline blood pressure and the maximum response in
cerebral blood flow. As MAP increases, changes in the maximum CBF response decreases
and even produces a decrease in CBF above 95 mmHg.
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Figure 2.3: Representative data set demonstrating the typical systemic response to a
phenylephrine bolus. The mean arterial pressure is shown in (A), the percent change in
cerebral blood flow and muscular blood flow in (B) and (C), respectively, and the absolute
change in total hemoglobin in the brain (D) and the muscle (E).

34

Figure 2.4: For all boluses that showed an increase in cerebral blood flow (CBF)(n=10),
mean arterial pressure (MAP) is shown in (A), cerebral total hemoglobin is shown in (C),
and percent change in CBF is shown in (E). For all boluses that showed a decrease in
CBF (n=4), MAP is shown in (B), cerebral total hemoglobin in (D) and percent change in
CBF in (F). The mean is shown in black, and the standard error is shown in blue shading.
* represents when the phenylephrine bolus was administered.
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Figure 2.5: For all boluses in the skeletal muscle (n=31), the average MAP is shown in
(A), the average change in total hemoglobin is shown in (B), and the average percent
change in blood flow is shown in (C). * represents when the phenylephrine bolus was
administered.

36

Figure 2.6: Relationship between the average baseline mean arterial blood pressure (prephenylephrine bolus) and the maximum percent change in cerebral blood flow.
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Table 1: Blood pressure data and the trends associated with each phenylephrine bolus. “I”
represents an increase at the time of injection, “D” represents a decrease at the time of
injection, and an “N” represents a lack of data for that bolus.
Animal
Date

Blood Pressure
Run

Baseline

HbT (h-NIRS)

Max Increase

Flow (DCS)

Brain

Leg

Brain

Leg

20200811

P1

71

50

I

D

I

D

20200811

P2

70

66

I

D

I

D

20200811

P3

78

55

I

D

I

D

20200811

P4

86

52

I

I

I

D

20200811

P5

92

45

I

D

D

D

20200818

P1

87

30

I

D

N

D

20200818

P2

95

31

I

D

N

D

20200818

P3

92

39

I

D

N

D

20200818

P4

87

37

I

D

N

D

20200818

P5

93

33

I

D

N

D

20200820

P1

105

30

D

D

N

D

20200820

P2

100

37

D

D

N

D

20200820

P3

110

40

D

D

N

D

20200820

P4

87

37

D

D

N

D

20200820

P5

91

32

D

D

N

D

20200820

P6

95

38

D

D

N

D

20200910

P1

105

28

D

D

N

D

20200910

P2

83

20

D

D

N

D

20200910

P3

92

31

N

D

N

D

20200910

P4

97

43

D

D

N

D

20200910

P5

101

36

I

D

N

D

20200910

P6

103

43

I

D

N

D

20200915

P1

81

35

I

D

I

D

20200915

P2

80

35

I

D

I

D

20200915

P3

83

57

I

D

I

D

20200915

P4

77

48

I

D

I

D

20200915

P5

78

56

D

D

I

D

20200917

P1

94

30

I

D

I

D

20200917

P2

98

32

I

D

D

D

20200917

P3

101

37

D

D

D

D

20200917

P4

98

36

D

D

D

D
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2.4 Discussion
Using a hybrid h-NIRS/DCS system to directly and continuously monitor the cerebral and
skeletal muscle microcirculation allows for non-invasive measurement of hemoglobin
concentration and blood flow. Such technology can be used to determine the effect of
phenylephrine across both microvascular beds. Both the MAP and the skeletal muscle
response were expected; that is increased in MAP and flow, and decreased HbT. However,
HbT and blood flow did not follow this same pattern in the brain, likely due to
autoregulation. This is the first report of simultaneous use of h-NIRS and DCS to monitor
the effects of phenylephrine on multiple microvascular beds in living animals.
The phenylephrine dosage was determined based on Yeh’s 1999 experiment; this dosage
caused a similar response to the desired effect in humans (Yeh, 1999). The effect of
phenylephrine on mean arterial pressure (MAP) is well documented (Thiele, 2011), and is
consistent with the findings of the current study. Baseline MAP stayed relatively constant,
with an average post-bolus increase of 31 mmHg. The consistency of the MAP response is
important to note; variability in microvascular responses was not due to fluctuating blood
pressure between boluses. Unlike MAP, the microvascular beds responded differently to
phenylephrine. Interestingly, HbT in the brain either showed a noticeable increase post
bolus, or a gradual decrease post bolus. Further, the response in the “decrease cerebral
flow” group had more variability.

Following the same trend as HbT, the cerebral blood flow either showed a noticeable
increase post bolus, or a gradual decrease post bolus. As seen in Figure 2.6, larger than
average baseline blood pressure was a precursor to a negative response. This pattern was
not seen in the skeletal muscle flow data, implying that cerebral autoregulation may play a
role in the observed CBF responses. It is important to note that these effects may be
different in a sick or otherwise unhealthy animal, as phenylephrine is most commonly used
to restore normal blood pressure and cerebral blood flow.

A benefit of near-simultaneous recording of two microvascular beds is that the response of
each organ can be compared for the same bolus. Phenylephrine causes vasoconstriction in
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arterioles in skeletal muscle, which is the driving force of the increase in MAP. As shown
in this work, this increase causes a varying effect on the cerebral microcirculation,
depending on the initial baseline MAP.

Cerebral autoregulation can be impaired by phenylephrine, which makes studying the
effects of phenylephrine on the brain microvasculature all the more important. The
phenylephrine bolus caused an increase in systemic blood pressure, but did not cause a
consistent response in the brain. When the baseline MAP was lower than 95 mmHg, blood
flow and HbT increased in the brain. In contrast, when the baseline MAP was higher than
95 mmHg, blood flow and HbT decreased. This data suggests that CAR works to increase
flow to the brain at baseline pressures lower than 95 mmHg, but decrease flow at pressures
higher than 95 mmHg. Since blood pressures above this point don’t cause CAR to increase
flow, the decrease seen may be due to the effects of phenylephrine on the large cerebral
arterioles similar to what is seen in the muscle. This is in direct contrast to the muscle,
which has no stringent protective effect like CAR to keep flow at a certain level. The
regularity of the MAP and the skeletal muscle flow response is consistent with skeletal
muscle being the driving force of the MAP increase, as muscle contraction and pressure
are stable. Higher blood pressures seen in hypertension are associated with structural
changes and dysfunctions that induce impaired cerebral autoregulation (Pires, 2013),
(Shekar, 2017). This impairment is reflected in these data, where the response in higher
blood pressures more closely mimics the response in skeletal muscle.

Our previous work (Mawdsley, 2021) has allowed the temporal resolution of the
phenylephrine response in these two microvascular beds to be discerned. Those time
courses showed that after an intravenous injection of phenylephrine, the microcirculation
responds within three seconds. Additionally, hemoglobin concentration did not return to
baseline levels during the collection window, suggesting that the collection window should
be extended to determine whether the collection window was not long enough if in fact
phenylephrine causes a lasting effect on hemoglobin and oxygen saturation levels. We
extended the collection window from six to ten minutes, and the microvascular data mostly
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returned to baseline in this time. As expected, the mean arterial pressure remained elevated
even with this longer collection time.

To continuously monitor the microvascular effects and avoid signal interference, 1-second
h-NIRS and DCS measurements of the brain/skeletal muscle were recorded successively,
with a full cycle occurred within 3.3sec. The use of two spectrometers allowed for h-NIRS
measurements in the brain and in the skeletal muscle to be recorded simultaneously. Based
on the time course data presented by Mawdsley (2021), we determined that a collection
length of one second would be sufficient to detect the peak response. An additional benefit
of acquiring h-NIRS and DCS simultaneously is the ability to measure scattering and
dynamic absorption coefficients to improve the accuracy of DCS measures.

Furthermore, global tissue blood flow has been shown to increase with phenylephrine
administration, but there is evidence that microvascular blood flow in some tissues
decreases as a result (Maier, 2009). This is supported by skeletal muscle data; the total
hemoglobin and flow decreased immediately post-bolus. However, they both increased to
near baseline levels within the measurement window. This again suggests that there may
be a brief period of blood flow redistribution. Future work will include incorporating
intravital video microscopy into the methodology to conclusively determine if there is
redistribution of flow in skeletal muscle after a phenylephrine bolus. Further, comparing
results from non-invasive optical methods such as h-NIRS and DCS to invasive results
obtained from intravital video microscopy would provide further insight into the response
of the skeletal muscle and brain microvasculature.
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Chapter 3

3 Conclusions
In this work we introduced a hybrid h-NIRS/DCS system that can continuously monitor
the cerebral and skeletal muscle microcirculation to allow for the non-invasive
measurement of tissue hemoglobin concentration and blood flow. Using this technology,
the effect of phenylephrine across both microvascular beds was determined. Both the MAP
response and the skeletal muscle response were expected; as MAP increased, blood flow
and HbT in skeletal muscle decreased. However, HbT in the brain and CBF did not follow
this same pattern, likely due to autoregulation.

Cerebral autoregulation disturbances are important to assess and control, especially in
clinical settings (Durduran, 2014). As the brain has no way to store oxygen and any
disruption in blood flow would quickly result in tissue oxygenation depletion (Boas, 2011).
Further, cerebral autoregulation can be impaired by phenylephrine, which makes studying
its effects on the brain microvasculature all the more important. The phenylephrine bolus
caused an increase in systemic blood pressure but did not cause a consistent response in
the brain. When the baseline MAP was lower than 95mmHg, blood flow and HbT increased
in the brain. In contrast, when the baseline MAP was higher than 95mmHg, blood flow and
HbT decreased. These findings suggest that CAR works to increase flow to the brain at
baseline pressures lower than 95 mmHg, but decrease flow at pressures higher than
95mmHg. Since blood pressures above this point don’t cause CAR to increase flow, the
decrease seen may be due to the effects of phenylephrine on the large cerebral arterioles
similar to what is seen in the muscle.

A benefit of near-simultaneous recording at two microvascular beds is that the response of
each organ to same bolus can be compared. Phenylephrine causes vasoconstriction in
arterioles in skeletal muscle, which is the driving force of the increase in MAP. The
response in the brain is in direct contrast to the muscle, which has no stringent protective
effect like CAR to keep flow at a certain level. The regularity of the MAP and the skeletal
muscle flow response is consistent with skeletal muscle being the driving force of the MAP
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increase, as muscle contraction and pressure are stable. Higher blood pressures seen in
hypertension are associated with structural changes and dysfunctions that induce impaired
cerebral autoregulation (Pires, 2013), (Shekar, 2017). This impairment is reflected in the
results of the current work, where the response at higher blood pressures more closely
mimics the response in skeletal muscle.

One limitation of this study is the near-simultaneous nature of the data collection. To
continuously monitor the microvascular effects and avoid signal interference, 1-second hNIRS and DCS measurements of the brain/skeletal muscle were recorded successively. To
avoid cross-talk between systems, the h-NIRS subsystem could not be collecting at the
same time as the DCS, and therefore the acquisition was not truly simultaneous. Data were
collected in 1-second intervals with a total cycle time of 3.3s, which was the closest to
simultaneous acquisition possible without impairing the integrity of the collected data.
Based on the time course data presented by Mawdsley et al (2021), we determined that a
collection length of one second would be sufficient to detect the peak response.

An additional benefit of acquiring h-NIRS and DCS simultaneously is the ability to capture
scattering and dynamic absorption coefficients to improve the accuracy of DCS measures.
However, this does bring forth a limitation - the estimated scattering coefficient from hNIRS is lower than what is obtained from time-resolved NIRS. This potentially affects the
accuracy of the DCS results. Due to the proportional nature of the absorption and the
scattering coefficient, the lower estimated scattering coefficient means the absorption
would be higher than expected. Changes in CBF are calculated instead of absolute values,
meaning the absolute value of the scattering and absorption coefficients aren’t important.
We accounted for the changes in these coefficients by incorporating the change in the
absorption coefficient into the DCS analysis.

While this work is important in determining microvascular blood flow patterns in small
animals, this specific set-up cannot be easily pivoted to adult humans. Both NIRS and DCS
have been successfully used in clinical work, mainly in neonates for CBF measurements
or skeletal muscle for children and adults. Due to the thickness of the adult human skull, a
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more advanced data analysis that account for the skull contribution will be needed to obtain
reliable cerebral measures in adult. Additionally, regional CBF measurements could be
needed, which would require multiple source-detector pair. Given the small size of the
adolescent rodent brain, it is reasonable to assume that flow to the majority of the brain
tissue was measured in this work.

Global tissue blood flow has been shown to increase with phenylephrine administration,
but there is evidence that microvascular blood flow in some tissues decreases as a result
(Maier, 2009). This is supported by the data shown for skeletal muscle as the average
response in total hemoglobin and in flow decreased immediately post-bolus. However, they
both increased to near baseline levels within the collection window. This again suggests
that there may be a brief period of blood flow redistribution. Future work will include
incorporating intravital video microscopy into the methodology to conclusively determine
if there is a redistribution of flow in skeletal muscle after a phenylephrine bolus. Further,
comparing results from non-invasive optical methods such as h-NIRS and DCS to invasive
results obtained from intravital video microscopy could provide new insight into the
response of the skeletal muscle and brain microvasculature to phenylephrine.

Using this hybrid device in conjunction with intravital video microscopy will aid in
determining disease progression in animal models. Many diseases have been shown to
exhibit microvascular dysfunction before the onset of any clinical symptoms, such as sepsis
and diabetes (Stehouwer, 2018), (Cade, 2008), (Ellis, 2005). A well-established sepsis
model (Bateman, 2015) results in a 4-6 hours sepsis progression from initiation to endpoint, and through intravital video microscopy the decline of microvascular health is clear.
Adding h-NIRS and DCS to this protocol would provide another measure of skeletal
muscle health, and more importantly a measure of cerebral health and the state of CAR
during each stage of sepsis. Since the h-NIRS/DCS system is non-invasive, it could be used
in both animal models and clinical studies which would aid in clinical translation of
findings in animal models to bedside treatment.
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This hybrid h-NIRS/DCS system is valuable for continuous in vivo monitoring (Rajaram,
2020a), (Rajaram, 2020b), and provides a unique method for concurrent monitoring of
hemodynamic parameters. Using h-NIRS and DCS simultaneously to directly and
continuously monitor hemodynamics in the brain and skeletal muscle microcirculation
during a phenylephrine injection provided new insight into the timing and impact of
vasoconstriction on major microvasculature beds, and the effect of cerebral autoregulation
on external factors. The technology used here can be successfully integrated into a variety
of drug and disease-based experiments to gain a clearer picture of the functioning of the
microcirculation.
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